Episode Details

Jimmy Bechtel sits down with Dr. Anastasia Christianson, former senior innovation leader at Pfizer and Johnson & Johnson, to talk about what a real AI strategy actually looks like in clinical research. They dig into why isolated pilots fall short, how to think about AI as a process change rather than a tool add-on, and where the biggest missed opportunities are right now. Dr. Christianson also shares her take on navigating evolving regulations and paints a picture of where clinical trials are headed over the next three to five years, including a future where no trial launches without first being simulated end to end.